Sandoz Ranitidine · DIN 02243230 · 300 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2021-03-01 — choose a marketed DIN from the same-category list.Discontinued March 1, 2021 · checked November 20, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2021-03-01 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2021-03-01 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Sandoz Ranitidine · DIN 02243230
Manufacturer: Sandoz Canada Inc.; listing date 2001-10-11
Health Canada: Cancelled post market since 2021-03-01 · brand SANDOZ RANITIDINE · ATC A02BA02 RANITIDINE · form Tablet · route Oral · ingredients RANITIDINE (RANITIDINE HYDROCHLORIDE) 300 MG · company Sandoz canada incorporated · schedule Prescription
Sandoz Ranitidine: Formulary list price $0.23 per unit (the source does not state the unit; exact figure $0.2253). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02243230)
Source record
DIN 02243230: Sandoz Ranitidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000020; group id 697; item number 1723; lccId None; manufacturer id SDZ
Source form: Tab; strength: 300mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2253; ministry $0.2253
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02243230
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=67116
Interchangeable products
Apo-Ranitidine · DIN 00733067 · $0.2253
Co Ranitidine · DIN 02248571 · $0.2253
Jamp-Ranitidine · DIN 02463725 · $0.2253
Mar-Ranitidine · DIN 02443716 · $0.2253
Mint-Ranitidine · DIN 02526387 · $0.2253
PMS-Ranitidine · DIN 02242454 · $0.2253
Ran-Ranitidine · DIN 02336502 · $0.2253
Teva-Ranitidine · DIN 00828556 · $0.2253
Zantac · DIN 02212358 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since March 1, 2021 — choose a marketed DIN from the same-category list.